SAN DIEGO, Jan. 07, 2021 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 9:10 a.m. ET. The conference will be conducted virtually, and the audio presentation will be available via https://jpmorgan.metameetings.net/events/healthcare21/sessions/35504-anaptysbio-inc/webcast?gpu_only=true&kiosk=true

Link:
AnaptysBio to Present at the 39th Annual J.P. Morgan Healthcare Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh